Skip to main content
Premium Trial:

Request an Annual Quote

NUS Spinout Endofotonics Launches with New Cancer Diagnosis Technology

NEW YORK (GenomeWeb News) – A new company spun out of the National University of Singapore (NUS) launched today with a technology that it said can instantly provide a diagnosis for gastric and esophageal cancers during endoscopy.

The company, Endofotonics, is further developing the in-vivo molecular diagnostic (IMDX) system for a commercial launch, possibly by 2018, according to its Co-founder and CEO Florence Leong.

The IMDX technology is an endoscopic device that uses computer software to analyze molecular information during a gastroscopic examination, and then provides a diagnosis. According to Endofotonics, IMDX "enables [an] objective cancer diagnosis to be available almost instantaneously during endoscopy."

IMDX consists of a spectroscopy system made up of a spectrum-stabilized near-infrared 785 nanometer diode laser; a high-throughput transmissive imaging spectrograph; a near-infrared-optimized charge-coupled device camera; a proprietary fiber-optic confocal Raman endoscopic probe; and a proprietary online customized computer-based software control system.

The technology was developed at NUS and is licensed exclusively to Endofotonics.

The company said that preliminary data showed IMDX has a diagnostic accuracy of better than 90 percent in gastric dysplasia, gastric cancer, and esophageal cancer. A lab prototype of the technology has been built, and the next step is to create a commercial prototype that can be manufactured that meets regulatory requirements.

Endofotonics has raised about S$700,000 (US$560,000) and is seeking government funding to support production of the IMDX system, it said.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.